- Home
- SAGE vs CYH Comparison
SAGE vs CYH Comparison
Compare SAGE & CYH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SAGE
- CYH
- Stock Information
- Founded
- SAGE 2010
- CYH 1985
- Country
- SAGE United States
- CYH United States
- Employees
- SAGE N/A
- CYH 60000
- Industry
- SAGE Biotechnology: Pharmaceutical Preparations
- CYH Hospital/Nursing Management
- Sector
- SAGE Health Care
- CYH Health Care
- Exchange
- SAGE Nasdaq
- CYH Nasdaq
- Market Cap
- SAGE 413.9M
- CYH 526.1M
- IPO Year
- SAGE 2014
- CYH 1991
- Fundamental
- Price
- SAGE $6.46
- CYH $3.88
- Analyst Decision
- SAGE Hold
- CYH Hold
- Analyst Count
- SAGE 19
- CYH 8
- Target Price
- SAGE $9.88
- CYH $4.27
- AVG Volume (30 Days)
- SAGE 815.0K
- CYH 3.4M
- Earning Date
- SAGE 04-29-2025
- CYH 07-23-2025
- Dividend Yield
- SAGE N/A
- CYH N/A
- EPS Growth
- SAGE N/A
- CYH N/A
- EPS
- SAGE N/A
- CYH N/A
- Revenue
- SAGE $47,404,000.00
- CYH $12,653,000,000.00
- Revenue This Year
- SAGE $103.73
- CYH N/A
- Revenue Next Year
- SAGE $41.15
- CYH $3.49
- P/E Ratio
- SAGE N/A
- CYH N/A
- Revenue Growth
- SAGE N/A
- CYH 1.05
- 52 Week Low
- SAGE $4.62
- CYH $2.24
- 52 Week High
- SAGE $13.47
- CYH $6.29
- Technical
- Relative Strength Index (RSI)
- SAGE 38.73
- CYH 61.33
- Support Level
- SAGE $6.36
- CYH $3.56
- Resistance Level
- SAGE $6.78
- CYH $3.96
- Average True Range (ATR)
- SAGE 0.24
- CYH 0.25
- MACD
- SAGE -0.01
- CYH -0.04
- Stochastic Oscillator
- SAGE 12.22
- CYH 35.16
About SAGE Sage Therapeutics Inc.
Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on brain health medicines. The company is targeting diseases and disorders of the brain with three key focus areas: depression, neurology and neuropsychiatry; also targeting two critical central nervous system, or CNS, receptor systems, GABA and NMDA. Its products ZURZUVAE is a medicine for the treatment of postpartum depression, or PPD, in adults, and ZULRESSO is a CIV injection for the treatment of postpartum depression in individuals 15 years old and older. It also has other drugs in its pipeline such as SAGE-324, Dalzanemdor (SAGE-718) among others.
About CYH Community Health Systems Inc.
Community Health Systems Inc is a publicly owned hospital operator in the United States. The company also owns four home health agencies and provides management and consulting services to independent hospitals. The firm derives revenue through a broad range of general and specialized hospital healthcare services and outpatient services.